integrated treatment for dual disorders kim mueser, ph.d. dartmouth medical school nh-dartmouth...

58
Integrated Treatment Integrated Treatment for Dual Disorders for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center [email protected]

Upload: nicholas-jefferson

Post on 27-Dec-2015

219 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Integrated Treatment Integrated Treatment for Dual Disordersfor Dual Disorders

Kim Mueser, Ph.D.Dartmouth Medical School

NH-Dartmouth Psychiatric Research Center

[email protected]

Page 2: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu
Page 3: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

OverviewOverview

• Epidemiology• Why focus on dual disorders?• Models of etiology• Assessment• Treatment principles• Research• Avoiding the blame/demoralization trap

Page 4: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Any Substance Use Disorder

0

10

20

30

40

50

60

Prev

alen

ce %

of S

ubst

ance

Use

Di

sord

er

Gen.Pop Schiz BPD MD OCD Phobia PD

Page 5: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Rates of Lifetime Substance Use Disorder (SUD) Rates of Lifetime Substance Use Disorder (SUD) among Recently Admitted Psychiatric Inpatients among Recently Admitted Psychiatric Inpatients

(N=325) (Mueser et al., 2000)(N=325) (Mueser et al., 2000)

0

25

50

75

100

% o

f C

lien

ts w

ith

SU

D

Schizophrenia Schizoaffective Disorder Bipolar Disorder Major Depression

Page 6: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Factors Influencing Factors Influencing Prevalence of Substance Prevalence of Substance

Use Disorders (SUD): Use Disorders (SUD): Client CharacteristicsClient Characteristics

Higher RatesHigher Rates• Males• Younger• Lower education• Single or never

married• Good premorbid

functioning

• History of childhood conduct disorder

• Antisocial personality disorder

• Higher affective symptoms

• Family history SUD

Page 7: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Factors Influencing Factors Influencing Prevalence of Substance Prevalence of Substance Use Disorders: Sampling Use Disorders: Sampling

LocationLocation

Higher RatesHigher Rates• Emergency rooms• Acute psychiatric

hospitals• Jails

• Homeless• Urban setting

(drugs)• Rural setting

(alcohol)

Page 8: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Major Subgroups of Major Subgroups of Comorbid ClientsComorbid Clients

• Severely mentally ill - psychotic Frequently abuse moderate amounts of

substances Small amounts of substance use trigger

negative consequences

• Anxiety and/or depression Substance use can cause or worsen

symptoms

Page 9: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Frequently abuse moderate to high amounts of substances

• Personality Disorders Antisocial & borderline most common Frequently abuse high amounts of

substances

Page 10: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Clinical EpidemiologyClinical Epidemiology

11. . Rates higher for people in treatment

22.. Approximately 50% lifetime, 25% 35% current substance abuse

33.. Rates are higher in acute care, institutional, shelter, and emergency settings

44.. Substance abuse is often missed in mental health settings

Page 11: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Why Focus on Dual Why Focus on Dual Disorders?Disorders?

11.. Substance abuse is the most common co-occurring disorder in persons with severemental disorders

22.. Significant negative outcomes related to substance abuse:

1) Clinical relapse & rehospitalization2) Demoralization

3) Family stress

4) Violent behavior

Page 12: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

1) Incarceration2) Homelessness3) Suicide 4) Medical illness 5) Infections diseases6) Early mortality

3.3. Outcomes improve when substance abuse remits

4.4. Poor treatment is expensive for families and society

Page 13: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Reasons for High Reasons for High Comorbidity Rates of Severe Comorbidity Rates of Severe Mental Illness and Substance Mental Illness and Substance

AbuseAbuse• Berkson’s Fallacy• Self-medication*• Super-sensitivity to effects of

substances*• Socialization motives• Precipitation of psychosis from

substance use

Page 14: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

• Common factors Poverty/deprivation Neurocognitive impairment Conduct disorder/antisocial

personality disorder

Page 15: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Self-MedicationSelf-Medication:: More symptomatic clients don’t abuse

more substances Substance selection unrelated to type of

symptoms experienced Types of substances abused unrelated to

psychiatric diagnosis Self-medication may contribute to some

comorbidity but doesn’t explain all More evidence supporting self-medication

in anxiety disorders (PTSD)

Page 16: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Super-sensitivity ModelSuper-sensitivity Model:: Biological sensitivity increases vulnerability to

effects of substances Smaller amounts of substances result in

problems “Normal” substance use is problematic for

clients with severe mental illness but not in general population

Sensitivity to substances, rather than high amounts of use, makes many clients with mental illness different from general population

Page 17: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Stress-Vulnerability ModelStress-Vulnerability Model

BiologicalVulnerability

SubstanceAbuse

Medication Stress Coping

Severityof SMI

Page 18: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Status of Moderate Drinkers Status of Moderate Drinkers with Schizophrenia 4 - 7 Years with Schizophrenia 4 - 7 Years

Later (N=45)Later (N=45)

55.6

20.0 24.4

0%

20%

40%

60%

80%

100%

Abstinent ModerateDrinker

AlcoholUse

Disorder

Source: Drake & Wallach (1993)

Page 19: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Support for Super-sensitivity ModelSupport for Super-sensitivity Model:: Dual disorder clients less likely to develop physical

dependence on substances Standard measures of substance abuse are less

sensitive in clients with severe mental illness Clients are more sensitive to effects of small

amounts of substances Few clients are able to sustain “moderate” use

without impairment Super-sensitivity accounts for some increased

comorbidity

Page 20: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Overview of Assessment Overview of Assessment of Substance Abuse in of Substance Abuse in

Clients with Severe Clients with Severe Mental IllnessMental Illness

Detection

Classification

Functional Assessment

Functional Analysis

Treatment Planning

Page 21: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

• Psychological DependencePsychological Dependence - - Use of more substance than intended, unsuccessful attempts to cut down, giving up important activities to use substances, or spending lots of time obtaining substances.

• Physical DependencePhysical Dependence - - Development of tolerance to effects of substance, withdrawal symptoms following cessation of substance use, use of

substance to decrease withdrawal symptoms.

Page 22: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Functional AssessmentFunctional Assessment• GoalsGoals:: To understand client’s functioning

across different domains and to gather information about substance use behavior

• Domains of FunctioningDomains of Functioning

1. 1. Psychiatric disorder

2.2. Physical health

3.3. Psychosocial adjustment (family & social relationships, leisure, work, education, finances, legal problems, spirituality)

Page 23: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

• Dimensions of Substance AbuseDimensions of Substance Abuse1.1. 6-Month Time-Line Follow-Back

Calendar2.2. Substances abused & route of administration3.3. Patterns of use4.4. Situations in which abuse occurs5.5. Reported motives for use

• Social• Coping• Recreational• Structure/sense of purpose

6.6. Consequences of use

Page 24: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Evaluating Social FactorsEvaluating Social FactorsAssociated with Associated with

Substance AbuseSubstance Abuse• Does person have non-substance abusing

peers?• Can person resist offers to use substances?• Is the person lonely?• Can the person initiate and maintain

conversations?• Is person able to get others to respond

positively to him/her?• Can the person express feelings? Resolve

conflicts?

Page 25: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Common Symptoms Common Symptoms AssociatedAssociated

with Self-Medicationwith Self-Medication

• Depression, suicidal thoughts• Anxiety, nervousness, tension• Hallucinations• Delusions of reference & paranoia• Sleep disturbance• Mania/hypomania

Page 26: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Recreational Skills and Recreational Skills and Substance AbuseSubstance Abuse

• What does the person do for fun?• Hobbies?• Sports?• What is person’s involvement with

others in recreational activities?• Does the person not participate in

activities which he/she previously did?

Page 27: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Functional AnalysisFunctional Analysis• GoalGoal:: To identify factors which influence or control

substance use behavior• Characteristics of Useful Functional AnalysesCharacteristics of Useful Functional Analyses

1. 1. Focus on behaviors, NOT stable traits2.2. Constructive, NOT eliminative3.3. Contextual, NOT mechanistic4. 4. Examines maintaining factors, NOT etiological

factors5.5. Leads to hypotheses that can be tested by

treatment & modified, NOT theories that remain unchanged regardless of outcome

6.6. Change usually doesn’t happen magically on its own

Page 28: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu
Page 29: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

•Constructing a Payoff MatrixConstructing a Payoff Matrix1. 1. List advantages & disadvantages of using

substances, & advantages & disadvantages of not using substances in Payoff Matrix

2.2. Use all available information from functional assessment

3.3. Consider advantages & disadvantages from theclient’s perspective

4. 4. View different reasons listed as hypothesesabout maintaining factors, not establishedfacts; reasons may change as new informationemerges

5.5. If client is using, the pros of using & cons ofnot using should outweigh the pros of notusing and cons of using

Page 30: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Pay-Off MatrixPay-Off Matrix

Advantages

Disadvan-tages

Using Substances Not Using Substances

Page 31: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Common Advantages and Disadvantages of Using Common Advantages and Disadvantages of Using Substances and Not Using SubstancesSubstances and Not Using Substances

Using Substances Not Using Substances

Advantages Feels good Acceptance & friendship when using with peers Decreased social anxiety Feel "normal" when using with others Escape from belief one is a "failure" or has not

lived up to expectations Relief from depression or anxiety Reduction or distraction from hallucinations Help getting to sleep Improved attention & concentration Decreased medication side effects Something to look forward to Reduction in craving or withdrawal symptoms

Better relationships with significant others Stable & independent housing Improved control & stability of psychiatric

illness Financial stability & control over one's

money Stay out of jail/prison Minimized exposure to infectious diseases

& better management of medical illnesses Reduced exposure to trauma Improved ability to pursue goals & meet

major role obligations (worker, student,spouse, parent)

Better social relationships, includingintimate relationships, with people whoreally care

No physical dependence

Disadvantages Conflict with significant others Housing instability & homelessness Relapses & rehospitalizations Financial problems Legal problems Infectious diseases & other medical illnesses Increased exposure to trauma Inability to pursue goals & meet major role

obligations (worker, student, spouse, parent) Physical dependence leading to need for greater

amounts Sociopathic or criminal social network Lack of an intimate relationship Increased hallucinations or paranoia

Lack of positive feelings Awkwardness or peer pressure from friends

who use substances Social isolation because no friends who

don't use Social anxiety Feel "abnormal" because of stigma from

mental illness Confrontation with belief that one is a

failure Persistent depression or anxiety Distress due to hallucinations Poor attention & concentration Troubling medication side effects Nothing to do or look forward to Cravings or withdrawal symptoms

Page 32: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Examples of Interventions Based on Examples of Interventions Based on the Payoff Matrixthe Payoff Matrix

Using Substances Not Using Substances

Advantages Naltrexone Disulfiram

Contingent reinforcement Community reinforcement Motivational interviewing Decisional balance method Education about dual disorders Persuasion groups

Disadvantages Disulfiram Financial payeeship Conditional discharge from

psychiatric hospital Probation or parole condition

Skills training for socialcompetence

Identifying new social outlets Teaching skills for coping

with distressful symptoms Pharmacological treatment of

distressful symptoms Developing alternative

recreational activities Creating new & meaning

pursuits (e.g., work, school,parenting)

Teaching strategies for copingwith cravings

Page 33: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Treatment PlanningTreatment Planning

• GoalsGoals: : To determine which interventions are most likely to be effective and how to measure outcome

• StepsSteps

1. 1. Engage the client and significant others

2.2. Assess motivation to change

Page 34: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

3.3. Select target behaviors, thoughts, emotions to change

4.4. Identify interventions to address targets: select at least 1 strategy to

enhance motivation & 1 strategy to address needs currently met by substance use

5.5. Choose measures to assess effects of intervention

Page 35: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu
Page 36: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Treatment BarriersTreatment Barriers

• Historical division of service and training

• Sequential and parallel treatments• Organizational and categorical funding

barriers in the public sector• Eligibility limits, benefit limits, and

payment limits in the private sector

Page 37: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Integrated TreatmentIntegrated Treatment

• Mental health and substance abuse treatmentDelivered concurrentlyBy the same team or group of

cliniciansWithin the same programThe burden of integration is on

the clinicians

Page 38: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Other Features of Dual Other Features of Dual Disorder ProgramsDisorder Programs

• Assertive outreach• Stage-wise treatment: engagement,

persuasion, active treatment, and relapse prevention

• Long-term commitment• Comprehensive treatment• Reduction of negative consequences

Page 39: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

What are the Stages of What are the Stages of Treatment?Treatment?

1.1. Engagement, persuasion, active treatment, and relapse prevention

2.2. Not linear

3.3. Stage determines goals

4.4. Goals determine interventions

5.5. Multiple options at each stage

Page 40: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

What Do We Do During What Do We Do During Engagement?Engagement?

• GoalGoal: : To establish a working alliance with the client

• Clinical StrategiesClinical Strategies1.1. Outreach

2.2. Practical assistance

3.3. Crisis intervention

4.4. Social network support

5.5. Legal constraints

Page 41: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

What Do We Do During What Do We Do During Persuasion?Persuasion?

• GoalGoal: : To motivate the client to address substance abuse as a problem

• Clinical StrategiesClinical Strategies

1.1. Psychiatric stabilization

2.2. “Persuasion” groups

3.3. Family psychoeducation

4.4. Rehabilitation

5.5. Structured activity

6.6. Education

7.7. Motivational interviewing

Page 42: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

What Do We Do During What Do We Do During Active Treatment?Active Treatment?

• Goal:Goal: To reduce client’s use/abuse of

substance

• Clinical StrategiesClinical Strategies1. 1. Self-monitoring

2. 2. Social skills training

3. 3. Social network interventions

4. 4. Self-help groups

Page 43: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

5. 5. Substitute activities

6. 6. Close monitoring

7. 7. Cognitive-behavioral techniques to address:High risk situationsCravingMotives for substance use

SocializationPersistent symptomsPleasure enhancement

Page 44: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

What Do We Do During What Do We Do During Relapse Prevention?Relapse Prevention?

• Goals:Goals: To maintain awareness of vulnerability and

expand recovery to other areas• Clinical StrategiesClinical Strategies

1.1. Self-help groups

2. 2. Cognitive-behavioral and supportive interventions to enhance functioning in:

Work, relationships, leisure activities, health, and quality of life

Page 45: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Relapse Prevention Relapse Prevention StrategiesStrategies

• Construction a relapse prevention plan:– Risky situations– Early warning signs– Immediate response– Social supports– Abstinence violation effect

Page 46: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Recovery MountainRecovery Mountain

• Combat demoralization related to relapses

• Reframe relapses as part of road to recovery

• Don’t loose sight of gains made between relapses

• Learning experience, modify relapse prevention plan

Page 47: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu
Page 48: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Stages of Substance Stages of Substance Abuse TreatmentAbuse Treatment

1. 1. Pre-engagementPre-engagement:: No contact with a counselor.

2. 2. EngagementEngagement:: Irregular contact with a counselor.

3. 3. Early PersuasionEarly Persuasion:: Regular contact with a counselor, but no reduction in substance abuse.

4. 4. Late PersuasionLate Persuasion: : Regular contact with a counselor and reduction in substance use (< 1 month).

Page 49: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

5. 5. Early Active TreatmentEarly Active Treatment:: Reduction in substance use (> 1 month).

6. 6. Late Active TreatmentLate Active Treatment:: No abuse for 1-6 months.

7. 7. Relapse PreventionRelapse Prevention:: No abuse 6-12 months.

8. 8. RemissionRemission:: No abuse for over one year.

Page 50: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Research on Integrated Research on Integrated Treatment (IT)Treatment (IT)

• 26+ RCT or quasi-experimental studies of IT (reviewed by Drake et al., 2004)

• 3/4 studies of brief motivational interviewing interventions showed positive effects

• 6/7 studies found group intervention better than 12-step or standard care

Page 51: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Research on IT (Cont.)Research on IT (Cont.)

• Family intervention: no RCTs examining family treatment alone

• Comprehensive IT: 2 RCT & 1 quasi-exp. study favor comp. IT over treatment as usual

• Intensity: more intensive IT produces slightly better outcomes (e.g., Drake et al., 1998)

Page 52: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Drake et al. (1998)Drake et al. (1998)

• 203 clients (77% schizophrenia)• ACT vs. standard case management (SCM)

(both IT)• 3 year follow-up• ACT better than SCM in alcohol severity &

stage of treatment• No differences in hospitalization, symptoms,

quality of life

Page 53: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

NH Dual Diagnosis StudyNH Dual Diagnosis Study

Proportion of Days in Stable Community Housing

0.7

0.8

0.9

1.0

Beginning 6 months 12 months 18 months 24 months 30 months 36 months

All DD Patients (N = 203) Patients in Recovery (N = 54)

1. Proportion of days in stable community housing (regular apartment or house, not in hospital, jail, homeless setting or doubling with friends or family) increased for all dual diagnosis clients.

2. They increased more rapidly for persons in recovery (no substance abuse for at least 6 months).

Page 54: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

NH Dual Diagnosis StudyNH Dual Diagnosis Study

1. Percentage of persons hospitalized during each six months declined significantly for all clients.

2. It declined much more for those in recovery.

Percentage of Persons Hospitalized

0.0

10.0

20.0

30.0

40.0

50.0

60.0

70.0

Beginning 6 months 12 months 18 months 24 months 30 months 36 months

All DD Patients (N = 203) Patients in Recovery (N = 54)

Page 55: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Fidelity to IT Model Fidelity to IT Model Improves OutcomeImproves Outcome

*** If current & subsequent points = 1 then the current score = 1Assessment Points Baseline 6 mo. 12 mo. 18 mo. 24 mo. 30 mo. 36 mo.Hi-Fidelity 0 19.67 26.23 29.51 37.7 42.62 55.74Low-Fidelity 0 3.85 3.85 7.69 7.69 15.38 15.38

Figure 1. Percent of Participants in Stable Remission for High-Fidelity ACT Programs (E ; n=61) vs. Low-Fidelity ACT Programs (G; n=26).

0

10

20

30

40

50

60

Baseline 6 mo. 12 mo. 18 mo. 24 mo. 30 mo. 36 mo.

Page 56: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Limitations of ResearchLimitations of Research

• Lack of standardization of treatments• No or limited fidelity assessment• No replication of program effects• Unclear or variable comparison

conditions

Page 57: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

Avoiding the Avoiding the Blame/Demoralization Blame/Demoralization

TrapTrapDon’t blame the client for substance Don’t blame the client for substance

abuse or relapses because:abuse or relapses because: Substance abuse is a disorder for which

clients are no more responsible than their primary psychiatric symptoms

Clients with most severe substance abuse need professional help the most; many others improve spontaneously

Remember that the clients are doing the best they can

Page 58: Integrated Treatment for Dual Disorders Kim Mueser, Ph.D. Dartmouth Medical School NH-Dartmouth Psychiatric Research Center Kim.t.mueser@dartmouth.edu

To avoid demoralizationTo avoid demoralization:: Remember: integrated treatment works in

the long run There is usually no obvious “best solution” Adopt a collaborative-empirical approach to

treatment View relapses as an inevitable part of the

recovery process Develop a case formulation based on a

functional analysis to guide treatment